Windlas Biotech Limited WINDLAS.NS Stock
Windlas Biotech Limited Price Chart
Windlas Biotech Limited WINDLAS.NS Financial and Trading Overview
| Windlas Biotech Limited stock price | 531.7 INR |
| Previous Close | 276.6 INR |
| Open | 278.9 INR |
| Bid | 301.35 INR x N/A |
| Ask | 302.15 INR x N/A |
| Day's Range | 278.9 - 317.5 INR |
| 52 Week Range | 203.25 - 317.5 INR |
| Volume | 782.22K INR |
| Avg. Volume | 29.95K INR |
| Market Cap | 6.32B INR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 15.340101 |
| EPS (TTM) | 25.17 INR |
| Forward Dividend & Yield | 3.5 (1.27%) |
| Ex-Dividend Date | September 9, 2022 |
| 1y Target Est | N/A |
WINDLAS.NS Valuation Measures
| Enterprise Value | 4.63B INR |
| Trailing P/E | 15.340101 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2323172 |
| Price/Book (mrq) | 1.600958 |
| Enterprise Value/Revenue | 0.902 |
| Enterprise Value/EBITDA | 7.684 |
Trading Information
Windlas Biotech Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 31.05% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 317.5 INR |
| 52 Week Low | 203.25 INR |
| 50-Day Moving Average | 263.52 INR |
| 200-Day Moving Average | 249.16 INR |
WINDLAS.NS Share Statistics
| Avg. Volume (3 month) | 29.95K INR |
| Avg. Daily Volume (10-Days) | 30.77K INR |
| Shares Outstanding | 20.8M |
| Float | 7.92M |
| Short Ratio | N/A |
| % Held by Insiders | 62.50% |
| % Held by Institutions | 10.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 1.44% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1777 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 8.30% |
| Operating Margin (ttm) | 9.32% |
| Gross Margin | 36.57% |
| EBITDA Margin | 11.73% |
Management Effectiveness
| Return on Assets (ttm) | 5.86% |
| Return on Equity (ttm) | 10.69% |
Income Statement
| Revenue (ttm) | 5.13B INR |
| Revenue Per Share (ttm) | 237.13 INR |
| Quarterly Revenue Growth (yoy) | 15.19% |
| Gross Profit (ttm) | N/A |
| EBITDA | 602.26M INR |
| Net Income Avi to Common (ttm) | 426.26M INR |
| Diluted EPS (ttm) | 19.7 |
| Quarterly Earnings Growth (yoy) | -22.60% |
Balance Sheet
| Total Cash (mrq) | 1.32B INR |
| Total Cash Per Share (mrq) | 61.93 INR |
| Total Debt (mrq) | 49.93M INR |
| Total Debt/Equity (mrq) | 1.24 INR |
| Current Ratio (mrq) | 2.916 |
| Book Value Per Share (mrq) | 188.762 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 609.65M INR |
| Levered Free Cash Flow (ttm) | -124577504 INR |
Profile of Windlas Biotech Limited
| Country | India |
| State | N/A |
| City | Gurugram |
| Address | 705-706, Vatika Professional Point |
| ZIP | 122001 |
| Phone | 91 12 4282 1030 |
| Website | https://windlas.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Windlas Biotech Limited, contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India. It offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. The company also provides manufactures various domestic trade generics and over-the-counter brands, which include nutraceutical and health supplement products through the online and offline channels. In addition, it manufactures pills, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. It exports its products primarily to Cambodia, Ivory Coast, the Philippines, Thailand, Vietnam, Myanmar, and Sri Lanka. The company was incorporated in 2001 and is based in Gurugram, India.
Q&A For Windlas Biotech Limited Stock
What is a current WINDLAS.NS stock price?
Windlas Biotech Limited WINDLAS.NS stock price today per share is 531.7 INR.
How to purchase Windlas Biotech Limited stock?
You can buy WINDLAS.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Windlas Biotech Limited?
The stock symbol or ticker of Windlas Biotech Limited is WINDLAS.NS.
Which industry does the Windlas Biotech Limited company belong to?
The Windlas Biotech Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Windlas Biotech Limited have in circulation?
The max supply of Windlas Biotech Limited shares is 20.8M.
What is Windlas Biotech Limited Price to Earnings Ratio (PE Ratio)?
Windlas Biotech Limited PE Ratio is 21.12435500 now.
What was Windlas Biotech Limited earnings per share over the trailing 12 months (TTM)?
Windlas Biotech Limited EPS is 25.17 INR over the trailing 12 months.
Which sector does the Windlas Biotech Limited company belong to?
The Windlas Biotech Limited sector is Healthcare.